Tesofensine – Yet another Trial Weight Loss Medication

Description

In the ongoing and never ending search for a technique to overcome obesity, NeuroSearch, the Danish Pharmaceutical company is setting up a medicine they hope have the FDA approval. This however maybe two to three years away because of all the hoops a medicinal drug needs to jump through in order to be approved. This latest fat reduction medication contains the generic name Tesofensine – http://search.about.com/?q=Tesofensine. If developed, it will without doubt have a trademarked name connected to it from NeuroSearch.
It’s gone through stage 2 trials with some very promising results but it is going to be the better complete stage three trials that will start to truly tell if this has potential of succeeding on the shelves shortly after or perhaps if it’ll go the way of Taranabant or Rimonabant and be discarded? The fundamental methodology of its is that it suppresses ones appetite as well as speeds up the metabolism of theirs thus allowing them to lose weight. However with every medication there will always be some reported negative effects – http://Www.blogher.com/search/apachesolr_search/negative%20effects which some of the subscribers of its could or even may well not encounter. So far some of these include mouth that is dry, constipation, insomnia as well as increase in heart rate. These along with other potential side effects will be the fire test of whether this will make it or not.
In the trials, folks are slimming down with this particular medication vs. a placebo and verses the once approved in Europe Rimonabant and that is clearly good news for NeuroSearch, but the reason why this study even far more valuable is that even in probably the lowest tested quantities, folks continue to be losing considerable best weight loss supplement while breastfeeding; look at here now – http://www.ortovivaistica.it/component/k2/itemlist/user/217562,. Several in the trials have also evidently reported not being to see some negative effects. But this is why there are test periods to determine the actual safety of the item before the public would be permitted to be prescribed it.
In October of 2008, a press release was launched claiming that not only is Tesofensine useful, but worked twice as well as rimonabant or sibutramine, which is a current diet treatment. But, unlike Rimonabant, there had been no reported cases of suicidal thoughts like the place reported with many while taking Rimonabant. And when taken at lower doses, there was not any great raise in blood pressure. It is going to be good to see what the more exhaustive stage three trials will produce.